Schedule 13G ownership disclosure
Aclaris Therapeutics Inc
Security class unavailable · CUSIP: 00461U105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,620,835
- Percent of class
- 8.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000215457-19-003192
- Form type
- SC 13G
- Filer
- Aclaris Therapeutics, Inc.
- CIK
- CIK 1557746
- Filed
- Feb 04, 2019
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership